Communicable disease threats report, 18-24 March 2012, week 12
Since November 2011, the so-called Schmallenberg virus (SBV) has been reported in cattle, sheep and goats in Germany, the Netherlands, Belgium, the United Kingdom, France, Luxembourg, Italy and now Spain. The Dutch Central Veterinary Institute found anti-SBV antibodies in 70 percent of samples taken from Dutch cattle between 1 November 2011 and 1 February 2012. This indicates widespread infection and an underestimation of total cases of infection with the virus.
The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2017
Cases of salmonellosis and campylobacteriosis have remained stable over the past five years, although listeriosis is on the rise. In 2017, there was an average of 100 food- and waterborne outbreaks per week.
Cross-border outbreak of extensively drug-resistant tuberculosis linked to a university in Romania
Popovici, O., Monk, P., Chemtob, D., Chiotan, D., Freidlin, P.J., Groenheit, R., Haanperä, M., Homorodean, D., Mansjö, M., Robinson, E., Rorman, E., Smith, G., Soini, H., Van Der Werf, M.J.
Genetic spatiotemporal anatomy of plasmodium vivax malaria episodes in Greece, 2009–2013
Spanakos, G., Snounou, G., Pervanidou, D., Alifrangis, M., Rosanas-Urgell, A., Baka, A., Tseroni, M., Vakali, A., Vassalou, E., Patsoula, E., Zeller, H., Van Bortel, W., Hadjichristodoulou, C.
Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
Cassini, A., Högberg, L.D., Plachouras, D., Quattrocchi, A., Hoxha, A., Simonsen, G.S., Colomb-Cotinat, M., Kretzschmar, M.E., Devleesschauwer, B., Cecchini, M., Ouakrim, D.A., Oliveira, T.C., Struelens, M.J., Suetens, C., Monnet, D.L., Strauss, R., Mertens, K., Struyf, T., Catry, B., Latour, K., Ivanov, I.N., Dobreva, E.G., Tambic Andraševic, A., Soprek, S., Budimir, A., Paphitou, N., Žemlicková, H., Schytte Olsen, S., Wolff Sönksen, U., Märtin, P., Ivanova, M., Lyytikäinen, O., Jalava, J., Coignard, B., Eckmanns, T., Abu Sin, M., Haller, S., Daikos, G.L., Gikas, A., Tsiodras, S., Kontopidou, F., Tóth, Á., Hajdu, Á., Guólaugsson, Ó., Kristinsson, K.G., Murchan, S., Burns, K., Pezzotti, P., Gagliotti, C., Dumpis, U., Liuimiene, A., Perrin, M., Borg, M.A., de Greeff, S.C., Monen, J.C., Koek, M.B., Elstrøm, P., Zabicka, D., Deptula, A., Hryniewicz, W., Caniça, M., Nogueira, P.J., Fernandes, P.A., Manageiro, V., Popescu, G.A., Serban, R.I., Schréterová, E., Litvová, S., Štefkovicová, M., Kolman, J., Klavs, I., Korošec, A., Aracil, B., Asensio, A., Pérez-Vázquez, M., Billström, H., Larsson, S., Reilly, J.S., Johnson, A., Hopkins, S.
Communicable disease threats report, 17-23 March 2019, week 12
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period from 17-23 March 2019 and includes updates on Middle East respiratory syndrome coronavirus (MERS-CoV), chikungunya virus disease and dengue, Ebola virus disease, influenza, Rift Valley fever and dengue in Réunion.
Rapid risk assessment: Extensively drug-resistant tuberculosis – multi-country cluster, Romania, 21 October 2016
This update was produced by ECDC after new information on the event background become available. The main conclusions and options for response remain unchanged from the version dated 19 October 2016.
Communicable disease threats report, 23-29 October 2016, week 43
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 23-29 October 2016 and includes updates on Zika virus, Salmonella and extensively drug-resistant TB.
Communicable disease threats report 18-24 Dec 2016, week 51
This ECDC Communicable Disease Threats Report covers 18-24 December 2016 and includes updates on Salmonella Stourbridge, type E botulism, hepatitis A, tuberculosis, cholera, influenza, measles, rubella, Legionnaires' disease and the Zika virus.
World Tuberculosis Day - 2016
Tuberculosis is a persistent public health threat but it could be eliminated if specific action is taken. In Europe, most countries have low TB rates. The disease tends to concentrates among the marginalised, the poorest and most vulnerable groups.